Journals / İstanbul Medical Journal / 2019 / Cilt: 20 - Sayı: 6

A Rare and Serious Complication of Percutaneous Renal Biopsy: Retroperitoneal Hemorrhage

Perkütan Böbrek Biyopsisinin Nadir ve Ciddi Bir Komplikasyonu: Retroperitoneal Hemoraji

Pages
568–570
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because ofmitral valve replacement history, a percutaneous renal biopsywas performed under low molecular weight heparin treatment.The follow-up and treatment process of retroperitonealhemorrhage after the procedure were described.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Renal biopsy is the gold standard diagnostic method inadults with the renal parenchymal disease.
📊
Key Findings & Data:The incidence of hemorrhagiccomplications due to interventional procedures in patients withenoxaparin use is 1.9-6.5%.
💡
Conclusion & Impact:Because ofmitral valve replacement history, a percutaneous renal biopsywas performed under low molecular weight heparin treatment.The follow-up and treatment process of retroperitonealhemorrhage after the procedure were described.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Renal biopsy is the gold standard diagnostic method inadults with the renal parenchymal disease. Retroperitonealhemorrhage is one of the rare and most severe complicationsof percutaneous renal biopsy. The incidence of hemorrhagiccomplications due to interventional procedures in patients withenoxaparin use is 1.9-6.5%. Patients undergoing percutaneousrenal biopsy under anti-coagulant therapy should be carefullymonitored for this potentially fatal complication after a biopsy.In this case report, we presented a 45-year-old female patientwho was admitted to our nephrology department for renalbiopsy for unexplained proteinuria and hematuria. Because ofmitral valve replacement history, a percutaneous renal biopsywas performed under low molecular weight heparin treatment.The follow-up and treatment process of retroperitonealhemorrhage after the procedure were described.

Özet

Böbrek biyopsisi renal parenkimal hastalığı olan erişkinlerde altın standart tanı yöntemidir. Retroperitoneal kanama perkütan renal biyopsinin nadir görülen ve en ciddi komplikasyonlarından biridir. Düşük molekül ağırlıklı heparin olan enoksaparin kullanılan hastalarda girişimsel işlemlere bağlı hemorajik komplikasyonların görülme insidansı %1,9- 6,5 arasındadır. Anti-koagülan tedavi altında perkütan renal biyopsi yapılan hastalar biyopsi sonrası ölümcül olabilen bu komplikasyon nedeniyle dikkatli izlenmelidir. Bu yazımızda açıklanamayan proteinüri ve hematüri nedeniyle nefroloji servisimize renal biyopsi amacıyla yatırılan 45 yaşında kadın hasta sunulmuştur. Mitral kapak replasman öyküsü nedeniyle hastaya düşük molekül ağırlıklı heparin tedavisi verilerek perkütan renal biyopsi yapılmıştır. İşlem sonrası gelişen retroperitoneal hemorajinin takip ve tedavi süreci anlatılmıştır.

🔖

Cite This Article

SELEN, T., OĞUZ, E. G., AYLI, M. D., ŞAHİN, H. (2022). A Rare and Serious Complication of Percutaneous Renal Biopsy: Retroperitoneal Hemorrhage. İstanbul Medical Journal, Cilt: 20 - Sayı: 6, 568–570. https://ajindex.com/articles/551954

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. McQuarrie EP, Mackinnon B, Young B, Yeoman L, Stewart G, Fleming S, et al. Scottish renal biopsy registry. Centre variation in incidence, indication and diagnosis of adult native renal biopsy in Scotland. Nephrol Dial Transplant 2009; 24: 1524-8
  2. Fuiano G, Mazza G, Comi N, Caglioti A, De Nicola L, Iodice C, et al. Current indications for renal biopsy: a question naire-based survey. Am J Kidney Dis 2000; 35: 448-57
  3. Printza N, Bosdou J, Pantzaki A, Badouraki M, Kollios K, Ghogha CH, et al. Percutaneous ultrasound-guided renal biopsy in children: A singlecentreexperience. Hippokratia 2011; 15: 258-61
  4. Topham PS, Chen Y: RenalBiopsy, in Floege J, Johnson RJ, Feehally J (eds), Comprehensive Clinical Nephrology (4th ed). Elsevier, 2010; 75-82
  5. Pirani CL: Evaluation of kidney biopsy specimens, In Tisher CG, Brenner BM (eds): Renal Pathology: With Clinical and Functional Correlations (2nd ed). Philadelphia, PA: Lippincott, 1994; 85-115
  6. Önen K: Böbrek hastalıklarının tanısı. Klinik Nefroloji. Çağlar Ş (ed). Ankara: Medial 1986: 57-99
  7. Karabulut Z, Dogan T, Asık M, Ergun T, Lakadamyalı H, Moray G. Enoksaparin ilişkili spontan retroperitoneal hematom. Türkiye Klinikleri Cardiovascular Sciences 2007; 3: 186-9
  8. Akgullu Ç, Yucel E, Aydın Ö, Sensoy B. Enoksaparin Kullanımına Bağlı Spontan Retroperitoniyal Kanama. Turkiye Klinikleri Cardiovascular Sciences 2008; 2: 124-7
  9. Börekci, E. İskemik İnme Sonrası Enoksaparine Bağlı Gelişen Retroperitoneal Kanama. J Contemp Med 2016; 6: 348-51
  10. Malik A, Capling R, Bastani B. Enoxaparin-associated retroperitoneal bleeding in two patients with renal insufficiency. Pharmacotherapy 2005; 25: 769-72
  11. Ernits M, Mohan PS, Fares LG, Hardy H. A retroperitoneal bleedin duced by enoxaparin therapy. Am Surg 2005; 71: 430-3
  12. Bergqvist D, Burmark US, Flordal PA, Frisell J, Hallböök T, Hedberg M, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995; 82: 496-501
  13. Kurtoğlu M, Büyükkurt CD, Kurtoğlu M, Dural AC, Güloğlu R, Akar U. Politravmatize yoğun bakım hastalarında düşük molekül ağırlıklı heparin ile venöz tromboembolizm proflilaksisi (genişletilmiş seri). Ulus Travma Derg 2003; 9: 37-44
  14. Chan-Tack KM. Fatal spontaneous retroperitoneal hematoma secondary to enoxaparin. South Med J 2003; 96: 58-60
  15. Dabney A, Bastani B. Enoxaparin-associated severe retroperitoneal bleeding and abdomina